The agency responsible for the medical insurance system in Israel in the Middle East has released a study showing that the effectiveness of the third vaccination against the new coronavirus is estimated to be 86% effective in preventing the onset of the disease in people over the age of 60.
In Israel, where more than 80% of people aged 16 and over have completed the second vaccination, the number of infected people has decreased sharply for a while, but it has increased again with the spread of the highly infectious mutant virus "Delta strain", and every day. About 8,000 people have been confirmed to be infected.
In addition, 80% of the people who became severely ill in the past month were over 60 years old.
For this reason, the Israeli government is currently promoting a third vaccination for people over the age of 50, and more than half of those over the age of 60 have already been vaccinated.
Under these circumstances, one of the organizations responsible for the medical insurance system, "McCabi," announced on the 18th the results of a survey on the initial stage of the third vaccination of Pfizer vaccines for people aged 60 and over.
According to this, when comparing 149,144 people who finished the third vaccination with 675,630 people who finished the second vaccination, infection was confirmed after the second vaccination of 37 people in the third group. In contrast, the second group had 1064 people.
As a result, it is estimated that 86% of people over the age of 60 are more effective in preventing the onset of the third vaccination.
"The third dose has been found to be effective in both aggravation and prevention of infection," said research expert Anat Eccazohar. "The third dose is the way to control the spread of the infection. Is emphasized.